{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:05:21Z","timestamp":1790669121329,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504594"],"award-info":[{"award-number":["82504594"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2021-46-2101-2023"],"award-info":[{"award-number":["Z-2021-46-2101-2023"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119085","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:11:34Z","timestamp":1782231094000},"page":"119085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting bacterial adhesion: Recent advances and therapeutic potential of FimH and PapG inhibitors against Escherichia coli infection"],"prefix":"10.1016","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4434-5988","authenticated-orcid":false,"given":"Panpan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetai","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-7310","authenticated-orcid":false,"given":"Yinhui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119085_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000989","article-title":"Can bacteria evolve resistance to quorum sensing disruption?","volume":"6","author":"Defoirdt","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119085_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2017.03.018","article-title":"Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents","volume":"131","author":"El-Gohary","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/med.20089","article-title":"Intervention with bacterial adhesion by multivalent carbohydrates","volume":"27","author":"Pieters","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119085_bib4","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1574-6976.2012.00342.x","article-title":"Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function","volume":"6","author":"Thanassi","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119085_bib5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.chom.2009.05.011","article-title":"Bacterial adhesins in host-microbe interactions","volume":"5","author":"Kline","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2026.119085_bib6","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1128\/AAC.02221-15","article-title":"Nitazoxanide inhibits pilus biogenesis by interfering with folding of the usher protein in the outer membrane","volume":"60","author":"Chahales","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119085_bib7","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1002\/ejoc.201100407","article-title":"The bacterial Lectin FimH, a target for drug discovery-carbohydrate inhibitors of type 1 fimbriae-mediated bacterial adhesion","volume":"20","author":"Hartmann","year":"2011","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/MMBR.00014-07","article-title":"Evolution of the Chaperone\/usher assembly pathway: fimbrial classification goes Greek","volume":"71","author":"Nuccio","year":"2007","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmech.2026.119085_bib9","first-page":"317","article-title":"Adhesive organelles of Gram-negative pathogens assembled with the classical chaperone\/usher machinery: structure and function from a clinical standpoint","volume":"3","author":"Vladimir","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119085_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yexmp.2008.03.007","article-title":"Origins and virulence mechanisms of uropathogenic Escherichia coli","volume":"85","author":"Wiles","year":"2008","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejmech.2026.119085_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10738","article-title":"Catch-bond mechanism of the bacterial adhesin FimH","volume":"7","author":"Sauer","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119085_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004857","article-title":"Inhibition and reversal of microbial attachment by an antibody with parasteric activity against the FimH adhesin of uropathogenic E. coli","volume":"11","author":"Kisiela","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119085_bib13","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/bi300251r","article-title":"The tyrosine gate as a potential entropic lever in the receptor-binding site of the bacterial adhesin FimH","volume":"51","author":"Wellens","year":"2012","journal-title":"Biochem"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119085_bib14","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1021\/acs.accounts.8b00397","article-title":"Development of mannopyranoside therapeutics against adherent-invasive Escherichia coli infections","volume":"51","author":"Mousavifar","year":"2018","journal-title":"Accounts of chemical research"},{"key":"10.1016\/j.ejmech.2026.119085_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/17460441.2017.1331216","article-title":"Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease","volume":"12","author":"Mydock-McGrane","year":"2017","journal-title":"Expert opin drug dis"},{"key":"10.1016\/j.ejmech.2026.119085_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/jambio\/lxag016","article-title":"Type 1 fimbrial protein FimH of Enterobacteriaceae-a promising target to mitigate different infections","volume":"137","author":"Thamayandhi","year":"2026","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119085_bib17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/265623a0","article-title":"Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors","volume":"265","author":"Ofek","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119085_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2958.2004.04415.x","article-title":"Receptor binding studies disclose a novel class of high\u2010affinity inhibitors of the Escherichia coli FimH adhesin","volume":"55","author":"Bouckaert","year":"2005","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119085_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/ea59d179-0a71-4836-86f0-8d375f5df089","article-title":"Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-Oligomannose-3 complex","volume":"3","author":"Wellens","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119085_bib20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/cbic.201600018","article-title":"The antiadhesive strategy in crohn' s disease: orally active mannosides to decolonize pathogenic Escherichia coli from the gut","volume":"17","author":"Alvarez Dorta","year":"2016","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2026.119085_bib21","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3390\/molecules22071101","article-title":"Sites for dynamic protein-carbohydrate interactions of O-and C-linked mannosides on the E. coli FimH adhesin","volume":"22","author":"Touaibia","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119085_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.01298-15","article-title":"Development of Heptylmannoside-Based glycoconjugate antiadhesive compounds against adherent-invasive Escherichia coli bacteria associated with crohn's disease","volume":"6","author":"Sivignon","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2026.119085_bib23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1039\/C4MD00093E","article-title":"Branched a-D-mannopyranosides: a new class of potent FimH antagonists","volume":"5","author":"Tomasic","year":"2014","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2026.119085_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.24820\/ark.5550190.p010.783","article-title":"Deciphering the conformation of C-linked \u03b1-D-mannopyranosides and their application toward the synthesis of low nanomolar E. Coli FimH ligands","volume":"7","author":"Mousavifar","year":"2018","journal-title":"ARKIVOC (Gainesville, FL, U. S.)"},{"key":"10.1016\/j.ejmech.2026.119085_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1107\/S2052252516002487","article-title":"Structures of C-mannosylated anti-adhesives bound to the type 1 fimbrial FimH adhesin","volume":"3","author":"Ruyck","year":"2016","journal-title":"IUCrJ"},{"key":"10.1016\/j.ejmech.2026.119085_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/pharmaceutics15020527","article-title":"Insightful improvement in the design of potent uropathogenic E. coli FimH antagonists","volume":"15","author":"Mousavifar","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119085_bib27","first-page":"421","article-title":"Synthesis and biological activity of mannose conjugates with 1-adamantamine and ferrocene amines","volume":"83","author":"Ribi\u0107","year":"2010","journal-title":"Croat. Chem. Acta"},{"key":"10.1016\/j.ejmech.2026.119085_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/aoc.1869","article-title":"Ferrocene conjugates with mannose: synthesis and influence of ferrocene aglycon on mannose\u2010mediated adhesion of Escherichia coli","volume":"26","author":"Kova\u010devi\u0107","year":"2012","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/aoc.3465","article-title":"Synthesis, spectral characterization and inhibitory potency of ferrocene\u2010containing mannosides towards type 1 fimbriated Escherichia coli","volume":"30","author":"Kova\u010d","year":"2016","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib30","first-page":"472","article-title":"Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells, infect","volume":"55","author":"Firon","year":"1987","journal-title":"Immun"},{"key":"10.1016\/j.ejmech.2026.119085_bib31","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1021\/jm100438s","article-title":"Structure-based drug design and optimization of mannoside bacterial FimH antagonists","volume":"53","author":"Han","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib32","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1021\/jm300165m","article-title":"Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides","volume":"55","author":"Han","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2533\/chimia.2012.166","article-title":"In vivo evaluation of FimH antagonists-a novel class of antimicrobials for the treatment of urinary tract infection","volume":"66","author":"Abgottspon","year":"2012","journal-title":"Chimia"},{"key":"10.1016\/j.ejmech.2026.119085_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003021","article-title":"Treatment and prevention of urinary tract infection with orally active FimH inhibitors","volume":"3","author":"Cusumano","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119085_bib35","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1021\/jm101011y","article-title":"FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to In Vitro and In vivo evaluation","volume":"53","author":"Klein","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib36","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1021\/jm501524q","article-title":"FimH antagonists: bioisosteres to improve the in Vitro and In Vivo PK\/PD profile","volume":"58","author":"Kleeb","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bbagen.2005.12.008","article-title":"Carbohydrates as future anti-adhesion drugs for infectious diseases","volume":"1760","author":"Sharon","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2026.119085_bib38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrmicro2220","article-title":"Structural biology of the chaperone-usher pathway of pilus biogenesis","volume":"7","author":"Waksman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119085_bib39","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1021\/acs.jmedchem.7b00342","article-title":"Urinary tract infection-which conformation of the bacterial Lectin FimH is therapeutically relevant?","volume":"60","author":"Mayer","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib40","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cmdc.201200125","article-title":"FimH antagonists: structure-activity and structure-property relationships for biphenyl \u03b1-D-Mannopyranosides","volume":"7","author":"Pang","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119085_bib41","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/cbic.201000774","article-title":"Squaric acid monoamide mannosides as ligands for the bacterial lectin FimH: covalent inhibition or not?","volume":"12","author":"Grabosch","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2026.119085_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/cmdc.201600006","article-title":"Antivirulence isoquinolone mannosides: optimization of the biaryl aglycone for FimH lectin binding affinity and efficacy in the treatment of chronic UTI","volume":"11","author":"Jarvis","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119085_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ab.2010.08.007","article-title":"Expression of the carbohydrate recognition domain of FimH and development of a competitive binding assay","volume":"407","author":"Rabbani","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2026.119085_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.mimet.2010.06.015","article-title":"Development of an aggregation assay to screen FimH antagonists","volume":"82","author":"Abgottspon","year":"2010","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.ejmech.2026.119085_bib45","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1021\/jm300192x","article-title":"Antiadhesion therapy for urinary tract Infections-A balanced PK\/PD profile proved to be key for success","volume":"55","author":"Jiang","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/cbdd.12329","article-title":"Mannosylated N-Aryl substituted 3-Hydroxypyridine-4-Ones: synthesis, hemagglutination inhibitory properties, and molecular modeling","volume":"84","author":"Car","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2026.119085_bib47","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1016\/j.bmc.2011.08.057","article-title":"Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists","volume":"19","author":"Schwardt","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.carres.2017.03.020","article-title":"Assembly and inhibitory activity of monovalent mannosides terminated with aromatic methyl esters: the effect of naphthyl groups","volume":"446","author":"Al-Mughaid","year":"2017","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2026.119085_bib49","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1021\/jm400723n","article-title":"Thiazolylaminomannosides as potent antiadhesives of type 1 piliated Escherichia coli isolated from Crohn's disease patients","volume":"56","author":"Brument","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib50","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/cmdc.201700061","article-title":"Physiochemical tuning of potent Escherichia coli anti\u2010adhesives by microencapsulation and methylene homologation","volume":"12","author":"Alvarez Dorta","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119085_bib51","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1039\/C6OB00424E","article-title":"Second generation of thiazolylmannosides, FimH antagonists for E.coli-Induced Crohn's disease","volume":"14","author":"Chalopin","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib52","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1021\/acs.jmedchem.6b00948","article-title":"Antivirulence C-mannosides as antibiotic-sparing, oral therapeutics for urinary tract infections","volume":"59","author":"Mydock-McGrane","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib53","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.bmcl.2018.06.017","article-title":"Synthesis and evaluation of thiomannosides, potent and orally active FimH inhibitor","volume":"28","author":"Sattigeri","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2026.119085_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107258","article-title":"Design, synthesis, biological evaluation and docking study of some new aryl and heteroaryl thiomannosides as FimH antagonists","volume":"145","author":"Mohammed","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119085_bib55","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1021\/acs.jmedchem.5b01923","article-title":"FimH antagonists: phosphate prodrugs improve oral bioavailability","volume":"59","author":"Kleeb","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib56","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/cmdc.200700063","article-title":"Mannosylated G(0) dendrimers with nanomolar affinities to Escherichia coli FimH","volume":"2","author":"Touaibia","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119085_bib57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3762\/bjoc.9.26","article-title":"Synthesis and testing of the first azobenzene mannobioside as photoswitchable ligand for the bacterial lectin FimH","volume":"9","author":"Chandrasekaran","year":"2013","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tetasy.2004.11.014","article-title":"Novel multivalent mannose compounds and their inhibition of the adhesion of type 1 fimbriated uropathogenic E. coli","volume":"16","author":"Appeldoorn","year":"2005","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2026.119085_bib59","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1002\/chem.201204015","article-title":"Heptyl \u03b1-D-Mannosides grafted on a \u03b2-Cyclodextrin core to interfere with Escherichia coli adhesion: an In Vivo multivalent effect","volume":"19","author":"Bouckaert","year":"2013","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2026.119085_bib60","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1039\/C0CC04468G","article-title":"The functional valency of dodecamannosylated fullerenes with Escherichia coli FimH-Towards novel bacterial antiadhesives","volume":"47","author":"Durka","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.119085_bib61","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1021\/mp200490b","article-title":"Diazo transfer and click chemistry in the solid phase syntheses of lysine-based glycodendrimers as antagonists against Escherichia coli FimH","volume":"9","author":"Papadopoulos","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2026.119085_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104876","article-title":"On-cell saturation transfer difference NMR for the identification of FimH ligands and inhibitors","author":"Palmioli","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib63","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/cmdc.200900034","article-title":"Synthetic multimeric heptyl mannosides as potent antiadhesives of uropathogenic Escherichia coli","volume":"4","author":"Gouin","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119085_bib64","doi-asserted-by":"crossref","first-page":"10029","DOI":"10.1002\/chem.201100515","article-title":"Clustering of Escherichia coli Type-1 fimbrial adhesins by using multimeric heptyl \u03b1-D-Mannoside probes with a carbohydrate core","volume":"17","author":"Almant","year":"2011","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2026.119085_bib65","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.1039\/C5OB01581B","article-title":"Inhibition profiles of mono- and polyvalent FimH antagonists against 10 different Escherichia coli strains","volume":"13","author":"Chalopin","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib66","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/acs.biomac.5b00413","article-title":"Glycopolymers as antiadhesives of E. coli strains inducing inflammatory bowel diseases","volume":"16","author":"Yan","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejmech.2026.119085_bib67","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.3390\/molecules30153074","article-title":"Bivalent inhibitors of mannose-specific bacterial adhesion: a xylose-based conformational switch to control glycoligand distance","volume":"30","author":"Jaeschke","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119085_bib68","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.carres.2011.04.023","article-title":"Bi-and trivalent glycopeptide mannopyranosides as inhibitors of type 1 fimbriae-mediated bacterial adhesion: variation of valency, aglycon and scaffolding","volume":"346","author":"Schierholt","year":"2011","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2026.119085_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103772","article-title":"Disperse red 15 (DR15) impedes biofilm formation of uropathogenic Escherichia coli","volume":"138","author":"Miryala","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejmech.2026.119085_bib70","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/molecules26030582","article-title":"Biocomputational prediction approach targeting FimH by natural SGLT2 inhibitors: a possible way to overcome the uropathogenic effect of SGLT2 inhibitor drugs","volume":"26","author":"Mashraqi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119085_bib71","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40203-024-00212-5","article-title":"The artificial neural network selects saccharides from natural sources a promise for potential FimH inhibitor to prevent UTI infections","volume":"12","author":"Dhanalakshmi","year":"2024","journal-title":"Silico Pharmacol"},{"key":"10.1016\/j.ejmech.2026.119085_bib72","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/antibiotics14040418","article-title":"Cranberry-derived phenolic compounds contribute to the inhibition of fimH-mediated Escherichia coli hemagglutination","volume":"14","author":"Ribi\u0107","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2026.119085_bib73","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/jgh.15828","article-title":"Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active crohn's disease","volume":"37","author":"Reinisch","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2026.119085_bib74","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40168-021-01135-5","article-title":"Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's disease","volume":"9","author":"Chevalier","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.ejmech.2026.119085_bib75","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1016\/j.csbj.2022.08.040","article-title":"Conserved FimH mutations in the global Escherichia coli ST131 multi-drug resistant lineage weaken interdomain interactions and alter adhesin function","volume":"20","author":"Qin","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2026.119085_bib76","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/glycob\/cwz059","article-title":"PapG subtype-specific binding characteristics of Escherichia coli towards globo-series glycosphingolipids of human kidney and bladder uroepithelial cells","volume":"29","author":"Nadine","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.ejmech.2026.119085_bib77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.ki.5002230","article-title":"Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney","volume":"72","author":"Lane","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejmech.2026.119085_bib78","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1021\/ja00198a056","article-title":"Probing of the combining site of the PapG adhesin of uropathogenic Escherichia coli bacteria by synthetic analogs of galabiose","volume":"111","author":"Kihlberg","year":"1989","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119085_bib79","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0968-0896(96)00163-0","article-title":"PapG adhesin from E. coliJ96 recognizes the same saccharide epitope when present on whole bacteria and as isolated protein","volume":"4","author":"Nilsson","year":"1996","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib80","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/chem.19960020310","article-title":"Synthesis, conformational analysis and comparative protein binding of a galabioside and its thioglycoside analogues","volume":"2","author":"Nilsson","year":"1996","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2026.119085_bib81","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0008-6215(98)00020-2","article-title":"Synthesis of some amino and carboxy analogs of galabiose; evaluation as inhibitors of the pilus protein PapGJ96 from Escherichia coli","volume":"307","author":"Hansen","year":"1998","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2026.119085_bib82","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0968-0896(03)00114-7","article-title":"Quantitative studies of the binding of the class II PapG adhesin from uropathogenic Escherichia coli to oligosaccharides","volume":"11","author":"Larsson","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib83","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1039\/B416878J","article-title":"Structure-activity relationships of galabioside derivatives as inhibitors of E. coli and S. suis adhesins: nanomolar inhibitors of S. suis adhesins","volume":"3","author":"Ohlsson","year":"2005","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2026.119085_bib84","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/1439-7633(20020802)3:8<772::AID-CBIC772>3.0.CO;2-8","article-title":"Discovery of potent inhibitors of PapG adhesins from uropathogenic Escherichia coli through synthesis and evaluation of galabiose derivatives","volume":"3","author":"Ohlsson","year":"2002","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2026.119085_bib85","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/jac\/dkm251","article-title":"Inhibition of P-fimbriated Escherichia coli adhesion by multivalent galabiose derivatives studied by a live-bacteria application of surface plasmon resonance","volume":"60","author":"Salminen","year":"2007","journal-title":"J. Antimicrob."},{"key":"10.1016\/j.ejmech.2026.119085_bib86","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/cbic.201600615","article-title":"Carbohydrate-lectin interactions: an unexpected contribution to affinity","volume":"18","author":"Navarra","year":"2017","journal-title":"Chembiochem"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:03:24Z","timestamp":1787040204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":86,"alternative-id":["S0223523426005301"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119085","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting bacterial adhesion: Recent advances and therapeutic potential of FimH and PapG inhibitors against Escherichia coli infection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119085"}}